Tumour localisation with a metal coil before the administration of neo-adjuvant chemotherapy

被引:11
作者
Nadeem, R
Chagla, LS
Harris, O
Desmond, S
Thind, R
Flavin, A
Audisio, RA
机构
[1] Univ Liverpool, Dept Gen Surg, Whiston Hosp, Prescot L35 5DR, Merseyside, England
[2] Whiston Hosp, Dept Surg, Prescot, England
[3] Whiston Hosp, Dept Radiol, Prescot, England
[4] Clatterbridge Ctr Oncol, Bebington, England
关键词
breast cancer; neo-adjuvant chemotherapy; metal coil; breast conserving surgery; localisation;
D O I
10.1016/j.breast.2004.11.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Complete clinical response (CR) with tumour disappearance is not uncommon after neo-adjuvant chemotherapy (NAC) for Locally advanced breast cancer, avoiding 25% mastectomies by facilitating breast-conserving procedures. We reviewed our series to understand the feasibility and utility of marking the cancer site before administering NAC. In total, 23 women (median age 47 years) with T2-4, N0-1, MO tumours were considered unsuitable for breast conserving surgery between January 2002 and November 2003, thus received NAC following a coil placement at the core of tumour. All patients had the coil successfully inserted and no migration or infection was recorded. Eight patients (35%) had a radiological CR (rCR) including 3 (13%) with pathological CR (pCR). In total, 87% patients were managed conservatively. The insertion of a metal. coil is a simple mean to provide a landmark for localisation and excision when the breast lump becomes impalpable and radiologically undetectable after the administration of NAC. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:403 / 407
页数:5
相关论文
共 30 条
[1]  
AUDISIO RA, IN PRESS ANN ROYAL C
[2]   The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: Preliminary results from national surgical adjuvant breast and bowel project protocol B-27 [J].
Bear, HD ;
Anderson, S ;
Brown, A ;
Smith, R ;
Mamounas, EP ;
Fisher, B ;
Margolese, R ;
Theoret, H ;
Soran, A ;
Wickerham, DL ;
Wolmark, N .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (22) :4165-4174
[3]  
Bear HD, 1998, SEMIN ONCOL, V25, P3
[4]   NEOADJUVANT CHEMOTHERAPY IN 126 OPERABLE BREAST CANCERS [J].
BELEMBAOGO, E ;
FEILLEL, V ;
CHOLLET, P ;
CURE, H ;
VERRELLE, P ;
KWIATKOWSKI, F ;
ACHARD, JL ;
LEBOUEDEC, G ;
CHASSAGNE, J ;
BIGNON, YJ ;
DELATOUR, M ;
LAFAYE, C ;
DAUPLAT, J .
EUROPEAN JOURNAL OF CANCER, 1992, 28A (4-5) :896-900
[5]   Primary chemotherapy in operable breast cancer: Eight-year experience at the Milan Cancer Institute [J].
Bonadonna, G ;
Valagussa, P ;
Brambilla, C ;
Ferrari, L ;
Moliterni, A ;
Terenziani, M ;
Zambetti, M .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) :93-100
[6]   Embolization coils as tumor markers for mammography in patients undergoing neoadjuvant chemotherapy for carcinoma of the breast [J].
Braeuning, MP ;
Burke, ET ;
Pisano, ED .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2000, 174 (01) :251-252
[7]  
BUZDAR AU, 2004, SIGNIFICANTLY HIGHER
[8]   US-guided implantation of metallic markers for permanent localization of the tumor bed in patients with breast cancer who undergo preoperative chemotherapy [J].
Edeiken, BS ;
Fornage, BD ;
Bedi, DG ;
Singletary, SE ;
Ibrahim, NK ;
Strom, EA ;
Holmes, F .
RADIOLOGY, 1999, 213 (03) :895-900
[9]   Primary chemotherapy in breast cancer - Correlation between tumor response and patient outcome [J].
Ferriere, JP ;
Assier, I ;
Cure, H ;
Charrier, S ;
Kwiatkowski, F ;
Achard, JL ;
Dauplat, J ;
Chollet, P .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (02) :117-120
[10]   Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-18 [J].
Fisher, B ;
Brown, A ;
Mamounas, E ;
Wieand, S ;
Robidoux, A ;
Margolese, RG ;
Cruz, AB ;
Fisher, ER ;
Wickerham, DL ;
Wolmark, N ;
DeCillis, A ;
Hoehn, JL ;
Lees, AW ;
Dimitrov, NV .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (07) :2483-2493